摘要 |
Disclosed are coumarin derived compounds of formula I as skin lightening agents alone or in combination with other skin benefit agents and together with a cosmetic vehicle: Where each or both R<SUB>1 </SUB>and/or R<SUB>2 </SUB>represents hydrogen (H); linear or branched, saturated or unsaturated C<SUB>1</SUB>-C<SUB>12 </SUB>alkyl, alkenyl, acyl, or heteroalkyl (preferably, alkoxy) groups; and R<SUB>3 </SUB>represents linear or branched, cyclic or acyclic, saturated or unsaturated C<SUB>1</SUB>-C<SUB>12 </SUB>alkyl, alkenyl, cycloalkyl, cycloalkenyl, or heteroalkyl group; and R<SUB>4 </SUB>represents a hydrogen atom (H); straight or branched, cyclic or acyclic, saturated or unsaturated, containing or not containing a heteroatom C<SUB>1</SUB>-C<SUB>22 </SUB>alkyl, alkenyl, cycloalkyl, cycloalkenyl, heteroalkyl, aryl, or heteroaryl group. In a most preferred embodiment, each R<SUB>1</SUB>, R<SUB>2 </SUB>and R<SUB>4 </SUB>represent H, while R<SUB>3 </SUB>represents a methyl group, referred to herein as a 4-methyl 7-hydroxy-coumarin derivative, or coumarin derived resorcinol derivative, which may be prepared by catalytic (nickel or paladium catalyst) hydrogenation of 4-methyl 7-hydroxy-coumarin followed by hydrolysis. The inventive compounds, compositions and methods have effective skin lightening properties, may be less irritating to the skin, and are cost-effective and relatively simple to manufacture. Also disclosed are processes for making the inventive compounds of general formula I from 4-substituted-7-hydroxy coumarin derivatives.
|